Further, we compared whether siRNA inhibition was more effective at pre- or post-ligation to ascertain the efficacy of MYOCD inhibition on cardiac hypertrophy and fibrosis under these two conditions. The gene discussed is MYOCD; the disease is cardiac hypertrophy.